Hospital Infection Therapeutics Market
According to Intent Market Research, the Hospital Infection Therapeutics Market is expected to grow from USD 11.2 billion in 2023 at a CAGR of 3.1% to touch USD 13.9 billion by 2030. The Hospital Infection Therapeutics Market is dominated by key players such as Pfizer Inc., Merck & Co., Inc., Johnson & Johnson, GlaxoSmithKline plc, Abbott Laboratories, Novartis International AG, Roche Holding AG, Sanofi S.A., AstraZeneca PLC, Bayer AG, Eli Lilly and Company, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Mylan N.V., Cipla Ltd.